Foghorn Therapeutics Statistics
Total Valuation
FHTX has a market cap or net worth of $119.36 million. The enterprise value is -$5.12 million.
| Market Cap | 119.36M |
| Enterprise Value | -5.12M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FHTX has 59.39 million shares outstanding. The number of shares has increased by 5.91% in one year.
| Current Share Class | 59.39M |
| Shares Outstanding | 59.39M |
| Shares Change (YoY) | +5.91% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 7.40% |
| Owned by Institutions (%) | 37.34% |
| Float | 25.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.25 |
| Forward PS | 2.98 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36
| Current Ratio | 3.36 |
| Quick Ratio | 3.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.92% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -44.81% |
| Weighted Average Cost of Capital (WACC) | 15.28% |
| Revenue Per Employee | $346,594 |
| Profits Per Employee | -$609,236 |
| Employee Count | 106 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.62% in the last 52 weeks. The beta is 3.01, so FHTX's price volatility has been higher than the market average.
| Beta (5Y) | 3.01 |
| 52-Week Price Change | -49.62% |
| 50-Day Moving Average | 4.35 |
| 200-Day Moving Average | 4.85 |
| Relative Strength Index (RSI) | 23.84 |
| Average Volume (20 Days) | 1,473,645 |
Short Selling Information
The latest short interest is 2.15 million, so 3.62% of the outstanding shares have been sold short.
| Short Interest | 2.15M |
| Short Previous Month | 1.99M |
| Short % of Shares Out | 3.62% |
| Short % of Float | 8.42% |
| Short Ratio (days to cover) | 4.85 |
Income Statement
In the last 12 months, FHTX had revenue of $36.74 million and -$64.58 million in losses. Loss per share was -$0.97.
| Revenue | 36.74M |
| Gross Profit | -42.09M |
| Operating Income | -68.48M |
| Pretax Income | -64.58M |
| Net Income | -64.58M |
| EBITDA | -66.35M |
| EBIT | -68.48M |
| Loss Per Share | -$0.97 |
Balance Sheet
The company has $167.58 million in cash and $43.10 million in debt, with a net cash position of $124.48 million or $2.10 per share.
| Cash & Cash Equivalents | 167.58M |
| Total Debt | 43.10M |
| Net Cash | 124.48M |
| Net Cash Per Share | $2.10 |
| Equity (Book Value) | -81.04M |
| Book Value Per Share | -1.38 |
| Working Capital | 119.47M |
Cash Flow
In the last 12 months, operating cash flow was -$84.24 million and capital expenditures -$50,000, giving a free cash flow of -$84.29 million.
| Operating Cash Flow | -84.24M |
| Capital Expenditures | -50,000 |
| Depreciation & Amortization | 2.12M |
| Net Borrowing | n/a |
| Free Cash Flow | -84.29M |
| FCF Per Share | -$1.42 |
Margins
Gross margin is -114.57%, with operating and profit margins of -186.38% and -175.78%.
| Gross Margin | -114.57% |
| Operating Margin | -186.38% |
| Pretax Margin | -175.78% |
| Profit Margin | -175.78% |
| EBITDA Margin | -180.61% |
| EBIT Margin | -186.38% |
| FCF Margin | n/a |
Dividends & Yields
FHTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.91% |
| Shareholder Yield | -5.91% |
| Earnings Yield | -54.10% |
| FCF Yield | -70.62% |
Analyst Forecast
The average price target for FHTX is $4.17, which is 107.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.17 |
| Price Target Difference | 107.46% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | -18.66% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FHTX has an Altman Z-Score of -4.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.17 |
| Piotroski F-Score | 3 |